India, UK trade pact does not mandate patent term extensions or data exclusivity
The move would protect the interests of the domestic generic drugs industry.
The UK was demanding for inclusion of 'data exclusivity" provision in the agreement.
'The FTA does not mandate patent term extensions or data exclusivity — two common tools of evergreening. India's patent law provisions on patentability criteria under Section 3(d) (of Indian Patent Act) remain fully protected," the ministry said.
Section 3(d) of the Indian Patents Act, 1970, restricts patents for already-known drugs unless the new claims are superior in terms of efficacy, while Section 3(b) bars patents for products that are against public interest and do not demonstrate enhanced efficacy over existing products.
Certain multinational firms have asked India to amend these laws, which were strongly opposed.
The agreement, signed on July 24, may take about a year to come into force.
Data exclusivity provides protection to the technical data generated by innovator companies to prove the usefulness of their products. In the pharmaceutical sector, drug companies generate data through expensive global clinical trials to prove the efficacy and safety of their new medicine.
By gaining exclusive rights over this data, innovator companies can prevent their competitors from obtaining a marketing licence for low-cost versions during the tenure of this exclusivity.
Earlier, India had also rejected a similar demand from the four-nation EFTA bloc in their free trade agreement negotiations.
The European Free Trade Association (EFTA) members are Iceland, Liechtenstein, Norway, and Switzerland. The pact was signed in March 2023 and will be implemented later this year.
The UK (AstraZeneca and GSK) and Switzerland (Novartis and Roche) have some of the major pharma firms of the world.
India's generic drug industry is estimated about USD 25 billion, and the country exports 50 per cent of its produce.
An expert said data exclusivity is beyond the provisions of the Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement under the World Trade Organization (WTO).
Evergreening of patent rights is a strategy allegedly adopted by the innovators having patent rights over products to renew them by bringing in some minor changes, such as adding new mixtures or formulations. It is done when their patent is about to expire. A patent on the new form gives the innovator company a 20-year monopoly on the drug.
'The FTA does not require India to provide patent term extensions for regulatory delays and data exclusivity for pharmaceuticals or agrochemicals," it said, adding that this ensures that generic manufacturers can enter the market without unnecessary delay, once the patent has expired or is challenged.
The agreement, it said, does not alter or dilute India's ability to refuse patents for minor modifications of known substances; and prevent frivolous or repetitive patent filings that block generics.
'There is no obligation for patent linkage or automatic injunctions either-key tools used to delay generics in other jurisdictions," the ministry said. PTI RR TRB
view comments
First Published:
July 28, 2025, 17:15 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
24 minutes ago
- Time of India
Tata Motors' PB Balaji to head Jaguar Land Rover as CEO
Tata Motors has announced the appointment of PB Balaji as the new Chief Executive Officer of Jaguar Land Rover ( JLR ), effective from November 17, 2025, according to the company's regulatory filings. He will succeed Adrian Mardell , who is retiring after a 35-year-long association with the UK-based luxury carmaker and who held the helm for three years. Mardell said, 'These three years have been a great privilege. We have cemented JLR's position in the automotive industry during a time of incredible change.' The board of JLR approved the appointment today. Balaji is currently serving as Group Chief Financial Officer of Tata Motors. N Chandrasekaran, Chairman of Tata Sons, Tata Motors and JLR, said, 'I would like to thank Adrian for the stellar turnaround of JLR and for delivering record results. I am delighted to appoint Balaji as the incoming CEO. He has been associated with the company for many years and has worked closely with the JLR leadership team. This move will ensure we continue to accelerate our journey to reimagine JLR.' Educational qualifications Balaji is an alumnus of IIT Madras and IIM Calcutta, and brings over three decades of experience across the automotive and consumer goods sectors. He joined Tata Motors in 2017 and has been instrumental in driving structural improvements in operations and financial performance. He has led diverse global teams across finance and supply chain roles in Mumbai, London, Singapore, and Switzerland. 'I look forward to leading this incredible company. Over the past eight years, I have grown to know and love its iconic brands. I thank Adrian for his immense contributions and wish him well in his next innings,' said Balaji. This appointment marks a significant step towards JLR's electrification and sustainability goals under its 'Reimagine' strategy.
The Hindu
24 minutes ago
- The Hindu
Trade unions, farm outfits demand parliamentary approval of trade treaties
A joint statement by ten Central Trade Unions (CTUs) and the Samyukt Kisan Morcha (SKM) on Monday (August 4, 2025) has demanded a parliamentary review of the Comprehensive Economic Trade Agreement (CETA) signed recently with the United Kingdom. The organisations asked the Union government to reject United States President Donald Trump's 'tariff threats' and assert India's sovereign right to trade with all nations, including Russia. The statement said the India-U.K. CETA must be reviewed and altered immediately, with no ratification in Parliament. 'All negotiations for a U.S.-India trade deal must be halted to prevent further corporate exploitation. No more secret trade agreements — all future deals must undergo full parliamentary scrutiny and public consultation,' the joint statement added. The organisations said East India Company colonised India through trade and today, CETA and U.S. trade deals are the new instruments of corporate imperialism. 'On August 13, farmers and workers will rise in defence of sovereignty and freedom, sending a clear message: We will not let history repeat! Quit India, again,' the statement added. Economic coercion by U.S. Terming the U.S. import tariffs on India as a blatant act of economic coercion, the trade unions and farmers' outfits said the new duties are aimed at dictating India including its trade relations with Russia. 'These aggressive measures expose the hypocrisy of U.S. trade policies, which demand open markets for American corporations while weaponising tariffs to bully sovereign nations,' they said. Alleging that the Centre has surrendered to these threats, the SKM and CTUs said it was further evident in the recently signed CETA, which according to them is a deal that sacrifices the interests of India's farmers, workers, and economic independence at the altar of foreign corporate profits. Compromising India's strategic autonomy 'Instead of firmly rejecting this intimidation, the Central government has responded with silence, signalling its willingness to compromise India's strategic autonomy in favour of U.S.A. This capitulation paves the way for an even more exploitative India-U.S. trade deal, which would grant American agribusiness corporations like Cargill unrestricted access to India's dairy sector, agriculture, resulting in collapsing prices and destroying the farming community along with endangering food security of the nation. It would also trigger de-industrialisation in India and skyrocketing unemployment,' the statement said.
News18
33 minutes ago
- News18
Siddaramaiah, Shivakumar condole Shibu Sorens demise
Agency: Bengaluru, Aug 4 (PTI) Karnataka Chief Minister Siddaramaiah on Monday condoled the death of former CM of Jharkhand, Shibu Soren, and said he was a towering figure in India's tribal rights movement. As the founding leader of Jharkhand Mukti Morcha, he dedicated his life to the creation of a separate Jharkhand and the upliftment of Adivasi communities, the chief minister said. 'Deeply saddened by the passing of Shri Shibu Soren-former Chief Minister of Jharkhand, former Union Minister, and a towering figure in India's tribal rights movement. My heartfelt condolences to Jharkhand CM @HemantSorenJMM, his family, and the people of Jharkhand in this moment of grief. His contributions to public life will be remembered with respect and gratitude," Siddaramaiah said in a post on 'X'. Deputy Chief Minister D K Shivakumar said he was deeply saddened by the passing of seasoned political leader, JMM founder and former CM of Jharkhand, Shibu Soren. 'His life was a powerful journey of struggle, courage, and commitment to the rights of tribal communities. Generations will remember his voice and vision. My thoughts and prayers are with @HemantSorenJMM and the entire family. Om Shanti," he said in a post in 'X'. Soren breathed his last at a private hospital in New Delhi while undergoing treatment for kidney-related problems. PTI AMP KH view comments First Published: August 04, 2025, 22:15 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
